# Hyster-Yale share price today (Hyster-Yale, Inc., HY)

> Hyster-Yale, Inc.'s share price has risen faster than its earnings: −11.9% in a year, against −142.3% for earnings per share. HY · Industrials · Farm & Heavy Construction Machinery · data as of 4 November 2026. Page: https://www.sectoralpha.in/us/stocks/hy

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Getting worse, from the last 12 quarters
- Price: $30.02 (−11.9% in a year)
- P/E: 279.4× (higher than 98% of the last 10 months)
- Revenue (Jun 2026): $813 M (−15.0% on a year ago)
- Profit (Jun 2026): −$31.6 M
- Operating margin: −6.5% (−7.1 points on a year ago)
- ROE: −12%, FY25
- ROIC: −11.0%, against a 9.3% cost of capital: −20.3 points

The main question: the share price moved −11.9% in a year while yearly earnings per share moved −142.3%. The difference came from the market paying a higher multiple. ## What is the Hyster-Yale share price today? Hyster-Yale, Inc.'s share price was $30.02 at the close on 4 November 2026. That is 12.5% below its average price over the last 200 trading days. In the last 52 weeks it traded between $28 and $40, and at that close it sat 15% of the way up from that low. Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 20 weeks running. Over the last 1 year the share price moved −29% while the S&P 500 moved +23%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 18 June 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Hyster-Yale pay? Hyster-Yale, Inc. paid $1.45 per share over the last four reported quarters. The most recent declaration was $0.36 for Jun 2026. At today's price of $30.02 that is a yield of 4.83%, based on dividends already paid, not a forecast. ## Which stock lists is Hyster-Yale on? Hyster-Yale is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is Hyster-Yale profitable? Hyster-Yale, Inc. posted a net loss of $31.6 M in the Jun 2026 quarter. The full FY25 year was a loss of $60.1 M. That loss is 3.9% of the quarter's revenue. The same quarter a year earlier lost $13.9 M. 5 of the last 12 reported quarters were loss-making. For the full year, FY25 profit was −$60.1 M (−142.2% on the year before). On average over the last four quarters, profit changed −392.6% and revenue −11.2%. Profit is growing slower than sales: rising costs are taking part of the growth. ## How much revenue does Hyster-Yale make, and is it growing? Hyster-Yale, Inc. reported $813 M of revenue in the Jun 2026 quarter, −15.0% on the same quarter a year earlier. Over 4 years it has grown 5.2% a year on average. The last full year, FY25, came in at $3.8 B. The last four reported quarters add to $3.5 B. FY25 revenue was $3.8 B, −12.5% on the year before. Recent pace: the last four quarters grew −11.2% on average, against 5.2% a year over the longer run, so this year is growing slower than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew −11.1%, against −9.1% a year over the last 8 quarters (stabilising). ## How much of every $100 of sales does Hyster-Yale keep? Hyster-Yale, Inc.'s operating margin was −6.5% in the Jun 2026 quarter, 7.1 percentage points lower than the same quarter a year ago. Across 5 years it has been between −3.0% and 6.1%. The latest quarter is below every full year in that period. Why the margin moved: operating margin changed −7.1 percentage points on the year while gross margin changed −6.2 points. So the drop came mostly from the gross margin, which means input costs and prices charged. ## Is Hyster-Yale's profit turning into cash? Over the last 2 years, 120% of Hyster-Yale, Inc.'s reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in $86.1 M of operating cash against −$60.1 M of profit. After $62.5 M of spending on assets, $23.6 M was left over as free cash. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does Hyster-Yale's cash go? Hyster-Yale, Inc. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $146 M on assets over the last 3 years. Averaged over those years that is 1.3% of FY25 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $146 M over the last 3 years. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Hyster-Yale's P/E ratio, and how does it compare with its own history? Hyster-Yale, Inc.'s P/E is 279.4×, about the highest it has ever been. Its usual P/E (the middle reading) is 228.4×, over 10 months of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved −142.3% while the price moved −11.9%. The price did better than earnings, which pushed the multiple up within its own range. In short: the multiple is high against its own past, so the earnings trend underneath matters more than the multiple. ## Is the Hyster-Yale business getting better or worse? Hyster-Yale, Inc.'s business is getting worse. Revenue, profit and EPS growth are shrinking: revenue growth is −11.1% in the latest quarter, against +20.1% at its best in 12 quarters, with ROCE falling at 7.8%. This is based on 12 quarters of 4 measures. Why it matters: falling lines mean any ratio below that looks low should be read with that direction in mind. ## How much does Hyster-Yale earn on its capital? Hyster-Yale, Inc. earned a ROE of −12% in FY25. That is up from a low of −45% in FY21. Its return on capital used (ROIC) is 20.3 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a −1.6% net margin and 1.87× asset turnover (sales divided by assets). Why the return is what it is (FY25): a −1.6% net margin × 1.87× asset turnover × 4.10× leverage (assets divided by equity) ≈ −12.3% on equity. The margin does its share; borrowing is a big part of it. The key test, return on capital used minus the cost of capital: −11.0% − 9.3% = −20.3 percentage points. The 9.3% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. The −11.0% ROIC above is the latest reading, as reported. The yearly chart below shows FY25 at 1.3%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does Hyster-Yale have too much debt? Hyster-Yale, Inc. has total debt of $500 M against shareholder equity of $410 M as of Jun 2026, so its debt is 1.22× its equity. Year by year, that ratio went from 1.54 in FY21 to 1.30 in FY25. Keep that borrowing in mind when reading the returns on this page. ## What is the Hyster-Yale shareholding pattern? 6.8% of Hyster-Yale, Inc.'s tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 4.8 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is Hyster-Yale from balance-sheet trouble? For Hyster-Yale, Inc., the Z-score is 2.24. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is in the grey area between the two. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 2.24 is in the grey area, neither clearly safe nor clearly in trouble. ## How does Hyster-Yale rank in its industry? 25.4 out of 100, rank 19 of 21 in Farm & Heavy Construction Machinery, with 64% of the evidence available. Hyster-Yale, Inc. scores 25.4 out of 100 against the 21 companies it is compared with in Farm & Heavy Construction Machinery, ranking 19. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 7.5 + 3.8 + 11 + 3.1 = 25.4. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Hyster-Yale compared with? Hyster-Yale ranks 19 of 21 Farm & Heavy Construction Machinery companies on the 4-Factor Sector Score, with 25.4 out of 100. 1. [Federal Signal Corporation](https://www.sectoralpha.in/us/stocks/fss) FSS · quiet · Most evidence points up · 81% evidence 68.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 25.1/35 · Revenue 23.9% · Profit 29% · Operating margin change 0.4 points · 83% evidence Capital efficiency 19.3/25 · ROCE 19.3% · Operating margin 17.7% · 76% evidence Valuation 11.6/20 · P/E 27.5× · PEG 0.93 · 65% evidence Relative strength 12.7/20 · Lead over its industry 2.6% · Lead over S&P 500 -3.8% · 1 year 6.5% · 100% evidence · 3 of 12 weeks ahead Exact sum: 25.1 + 19.3 + 11.6 + 12.7 = 68.7 · What this means: Earnings, capital efficiency and relative strength all agree. The open questions are about management, upcoming events and risks. 2. [The Manitowoc Company, Inc.](https://www.sectoralpha.in/us/stocks/mtw) MTW · leader · Evidence leans up · 81% evidence 62.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.3/35 · Revenue 8.8% · Profit -56.5% · Operating margin change 3.7 points · 83% evidence Capital efficiency 8.4/25 · ROCE 5.8% · Operating margin 5.7% · 76% evidence Valuation 14.9/20 · P/E 24.7× · PEG 0.13 · 65% evidence Relative strength 19.6/20 · Lead over its industry 53.9% · Lead over S&P 500 44.7% · 1 year 112.1% · 100% evidence · 12 of 12 weeks ahead Exact sum: 19.3 + 8.4 + 14.9 + 19.6 = 62.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Caterpillar Inc.](https://www.sectoralpha.in/us/stocks/cat) CAT · quiet · Evidence leans up · 85% evidence 61.0 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 28.9/35 · Revenue 20.3% · Profit 27.6% · Operating margin change 2.8 points · 95% evidence Capital efficiency 21.1/25 · ROCE 22.7% · Operating margin 20.5% · 76% evidence Valuation 10.5/20 · P/E 31.5× · PEG 1.02 · 65% evidence Relative strength 0.5/20 · Lead over its industry -22.3% · Lead over S&P 500 -27% · 1 year 5% · 100% evidence · 0 of 12 weeks ahead Exact sum: 28.9 + 21.1 + 10.5 + 0.5 = 61 · What this means: Earnings are strong; relative strength in its sector is -22.3% and the one-year return is 5%. 4. [Deere & Company](https://www.sectoralpha.in/us/stocks/de) DE · leader · Evidence leans up · 85% evidence 59.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 16.1/35 · Revenue 8.3% · Profit -6.4% · Operating margin change -1.7 points · 95% evidence Capital efficiency 14.3/25 · ROCE 9.1% · Operating margin 13.4% · 76% evidence Valuation 10.7/20 · P/E 32.8× · PEG 1 · 65% evidence Relative strength 18.6/20 · Lead over its industry 16.4% · Lead over S&P 500 9.1% · 1 year 44.6% · 100% evidence · 9 of 12 weeks ahead Exact sum: 16.1 + 14.3 + 10.7 + 18.6 = 59.7 · What this means: Relative strength against the index is 9.1%, and revenue and profit growth are weak. 5. [Blue Bird Corporation](https://www.sectoralpha.in/us/stocks/blbd) BLBD · quiet · Evidence leans up · 81% evidence 59.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 18.1/35 · Revenue 13.4% · Profit 100% · Operating margin change -0.6 points · 83% evidence Capital efficiency 17.6/25 · ROCE 22.2% · Operating margin 12.1% · 76% evidence Valuation 15.2/20 · P/E 8.8× · PEG 0.5 · 65% evidence Relative strength 8.6/20 · Lead over its industry 0.3% · Lead over S&P 500 -5.8% · 1 year 21.1% · 100% evidence · 0 of 12 weeks ahead Exact sum: 18.1 + 17.6 + 15.2 + 8.6 = 59.5 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [AGCO Corporation](https://www.sectoralpha.in/us/stocks/agco) AGCO · turning · Evidence leans up · 81% evidence 56.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.6/35 · Revenue 1.7% · Profit 100% · Operating margin change -1.7 points · 83% evidence Capital efficiency 10.8/25 · ROCE 8.6% · Operating margin 5.7% · 76% evidence Valuation 14.6/20 · P/E 16.2× · PEG 0.58 · 65% evidence Relative strength 11.4/20 · Lead over its industry -1.5% · Lead over S&P 500 -7.9% · 1 year 6.8% · 100% evidence · 3 of 12 weeks ahead Exact sum: 19.6 + 10.8 + 14.6 + 11.4 = 56.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [Gencor Industries, Inc.](https://www.sectoralpha.in/us/stocks/genc) GENC · leader · Evidence leans up · 81% evidence 56.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 16.5/35 · Revenue -5.1% · Profit 0% · Operating margin change 5.6 points · 83% evidence Capital efficiency 11.0/25 · ROCE 5.7% · Operating margin 17.2% · 76% evidence Valuation 9.7/20 · P/E 14.7× · PEG 1.49 · 65% evidence Relative strength 19.0/20 · Lead over its industry 14.7% · Lead over S&P 500 7.7% · 1 year 29% · 100% evidence · 12 of 12 weeks ahead Exact sum: 16.5 + 11 + 9.7 + 19 = 56.2 · What this means: Relative strength against the index is 7.7%, and revenue and profit growth are weak. 8. [Columbus McKinnon Corporation](https://www.sectoralpha.in/us/stocks/cmco) CMCO · losing its lead · Evidence leans up · 64% evidence 55.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 23.3/35 · Revenue 55.3% · Profit n/a · Operating margin change 8.2 points · 62% evidence Capital efficiency 8.6/25 · ROCE 2.8% · Operating margin 10.4% · 76% evidence Valuation 8.5/20 · P/E 81.5× · PEG n/a · 15% evidence Relative strength 14.7/20 · Lead over its industry 11.9% · Lead over S&P 500 4.5% · 1 year 18.8% · 100% evidence · 8 of 12 weeks ahead Exact sum: 23.3 + 8.6 + 8.5 + 14.7 = 55.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Oshkosh Corporation](https://www.sectoralpha.in/us/stocks/osk) OSK · quiet · Evidence leans down · 81% evidence 49.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 11.8/35 · Revenue 2.2% · Profit -14.5% · Operating margin change -2.5 points · 83% evidence Capital efficiency 14.3/25 · ROCE 11.5% · Operating margin 8.4% · 76% evidence Valuation 13.7/20 · P/E 17.2× · PEG 0.65 · 65% evidence Relative strength 9.8/20 · Lead over its industry 0.2% · Lead over S&P 500 -6.5% · 1 year 18.1% · 100% evidence · 3 of 12 weeks ahead Exact sum: 11.8 + 14.3 + 13.7 + 9.8 = 49.6 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far. 10. [CNH Industrial N.V.](https://www.sectoralpha.in/us/stocks/cnh) CNH · breaking out · Evidence leans down · 81% evidence 49.5 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 11.7/35 · Revenue 0.6% · Profit -63.2% · Operating margin change -0.9 points · 83% evidence Capital efficiency 8.1/25 · ROCE 1.7% · Operating margin 5.5% · 76% evidence Valuation 13.8/20 · P/E 44.8× · PEG 0.49 · 65% evidence Relative strength 15.9/20 · Lead over its industry 6.3% · Lead over S&P 500 -0.6% · 1 year 21.2% · 100% evidence · 11 of 12 weeks ahead Exact sum: 11.7 + 8.1 + 13.8 + 15.9 = 49.5 · What this means: Relative strength against the index is -0.6%, and revenue and profit growth are weak. 11. [Aebi Schmidt Holding AG](https://www.sectoralpha.in/us/stocks/aebi) AEBI · quiet · Evidence leans down · 64% evidence 44.1 out of 100 Growth Capital Valuation Relative
12. [Wabash National Corporation](https://www.sectoralpha.in/us/stocks/wnc) WNC · quiet · Evidence leans down · 64% evidence 43.4 out of 100 Growth Capital Valuation Relative
13. [Alamo Group Inc.](https://www.sectoralpha.in/us/stocks/alg) ALG · quiet · Evidence leans down · 81% evidence 42.2 out of 100 Growth Capital Valuation Relative
14. [Lindsay Corporation](https://www.sectoralpha.in/us/stocks/lnn) LNN · quiet · Evidence leans down · 85% evidence 42.1 out of 100 Growth Capital Valuation Relative
15. [Terex Corporation](https://www.sectoralpha.in/us/stocks/tex) TEX · quiet · Evidence leans down · 81% evidence 40.9 out of 100 Growth Capital Valuation Relative
16. [PACCAR Inc](https://www.sectoralpha.in/us/stocks/pcar) PCAR · quiet · Evidence leans down · 81% evidence 40.1 out of 100 Growth Capital Valuation Relative
17. [Titan International, Inc.](https://www.sectoralpha.in/us/stocks/twi) TWI · quiet · Evidence leans down · 64% evidence 36.4 out of 100 Growth Capital Valuation Relative
18. [Astec Industries, Inc.](https://www.sectoralpha.in/us/stocks/aste) ASTE · basing · Most evidence points down · 71% evidence 32.9 out of 100 Growth Capital Valuation Relative
19. Hyster-Yale, Inc. this page HY · quiet · Most evidence points down · 64% evidence 25.4 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 7.5/35 · Revenue -11.2% · Profit -636.4% · Operating margin change -7.1 points · 62% evidence Capital efficiency 3.8/25 · ROCE -10.1% · Operating margin -6.5% · 76% evidence Valuation 11.0/20 · P/E 7.4× · PEG n/a · 15% evidence Relative strength 3.1/20 · Lead over its industry -10.8% · Lead over S&P 500 -16.6% · 1 year -11.9% · 100% evidence · 0 of 12 weeks ahead Exact sum: 7.5 + 3.8 + 11 + 3.1 = 25.4 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 20. SunScout Holding Limited SNSC · Too little evidence to rank firmly · 19% evidence 57.7 out of 100 Growth Capital Valuation Relative
21. CEA Industries Inc. BNC · Too little evidence to rank firmly · 47% evidence 25.9 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Farm & Heavy Construction Machinery](https://www.sectoralpha.in/us/sectors/farm-heavy-construction-machinery), all 21 compared on one page. ## Which companies are close to Hyster-Yale in size? Hyster-Yale is the 15th largest of 19 Farm & Heavy Construction Machinery companies on Sector Alpha by market value (scores of 4 November 2026). Just above it: Astec Industries, Inc., Aebi Schmidt Holding AG and The Manitowoc Company, Inc. Just below it: Columbus McKinnon Corporation, Wabash National Corporation and Titan International, Inc. ### Farm & Heavy Construction Machinery companies close in size

1. [Astec Industries, Inc.](https://www.sectoralpha.in/us/stocks/aste) $905 million
2. [Aebi Schmidt Holding AG](https://www.sectoralpha.in/us/stocks/aebi) $903 million
3. [The Manitowoc Company, Inc.](https://www.sectoralpha.in/us/stocks/mtw) $838 million
4. Hyster-Yale, Inc. $538 million
5. [Columbus McKinnon Corporation](https://www.sectoralpha.in/us/stocks/cmco) $531 million
6. [Wabash National Corporation](https://www.sectoralpha.in/us/stocks/wnc) $472 million
7. [Titan International, Inc.](https://www.sectoralpha.in/us/stocks/twi) $315 million

[All 19 Farm & Heavy Construction Machinery companies, largest first](https://www.sectoralpha.in/us/sectors/farm-heavy-construction-machinery#all-companies)

### Companies close in size in other industries

1. [Valneva SE](https://www.sectoralpha.in/us/stocks/valn) $526 million · Biotechnology
2. [Ennis, Inc.](https://www.sectoralpha.in/us/stocks/ebf) $525 million · Business Equipment & Supplies
3. Hyster-Yale, Inc. $524 million
4. [MasterCraft Boat Holdings, Inc.](https://www.sectoralpha.in/us/stocks/mcft) $523 million · Recreational Vehicles
5. [West Bancorporation, Inc.](https://www.sectoralpha.in/us/stocks/wtba) $521 million · Banks - Regional

## What else do people ask about Hyster-Yale? ### What were Hyster-Yale's latest quarterly results? Hyster-Yale, Inc. reported revenue of $813 M and a net loss of $31.6 M for the Jun 2026 quarter. Earnings per share were −$1.76. The operating margin was −6.5%, 7.1 percentage points lower than a year earlier (as of 4 November 2026). ### What is Hyster-Yale's market cap? Hyster-Yale, Inc.'s market capitalisation is $538 M at a stock price of $30.02. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 4 November 2026). ### How is Hyster-Yale performing? Hyster-Yale, Inc.'s latest readings are below. Over the past 13 weeks it has done worse than the S&P 500, for 20 weeks running. This describes what the data did, not a rating (as of 4 November 2026). ### Will Hyster-Yale's stock price go up? This page does not forecast Hyster-Yale, Inc.'s stock price. What it shows instead: the stock price is $30.02. Its P/E of 279.4× is higher than 98% of its own last 1 years. Nobody can reliably say which way a price will move, and this site does not try (as of 4 November 2026). ### Is Hyster-Yale's profit real cash? Yes, over the last 2 years, 120% of Hyster-Yale, Inc.'s reported profit came in as cash from operations. The latest year was lower at -143%, so the trend is worth watching. In FY25, operating cash was $86.1 M against reported profit of −$60.1 M. Most of that cash then goes into building new capacity. These are yearly figures (as of 4 November 2026). ### Where is Hyster-Yale in its business cycle? Hyster-Yale, Inc.'s FY25 operating margin was 0.3%, against a 5-year range of −3.0% to 6.1%: the middle of its own range, neither a peak nor a low. The latest quarter was −6.5%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 4 November 2026). ### What could break the Hyster-Yale story? The main question: the share price moved −11.9% in a year while yearly earnings per share moved −142.3%. The difference came from the market paying a higher multiple. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 4 November 2026). ### Is Hyster-Yale a stock worth studying right now? What the numbers show: Hyster-Yale, Inc.'s share price has risen faster than its earnings: −11.9% in a year, against −142.3% for earnings per share. The main open question: whether earnings grow into a price that has already moved. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 4 November 2026). This is research, not advice. We’re not SEBI-registered.